Skip to main content
Black Friday Sale - Get 40% off Vantage
Published loading...Updated

First Mechanistic Classification of Drugs that Can Cause Fatty Liver

Summary by RUVID
Research staff from the University of Valencia (UV) and the Instituto de Investigación Sanitaria La Fe (IIS La Fe), integrated into the CIBER of Hepatic and Digestive Diseases (CIBERHED) have developed the first clinical and mechanistic classification of drugs capable of inducing fatty liver in patients who consume them. This classification, which describes the biological and molecular mechanisms that explain how these drugs cause liver damage, …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

Research staff from the University of Valencia (UV) and the Instituto de Investigación Sanitaria La Fe (IIS La Fe), integrated into the CIBER of Hepatic and Digestive Diseases (CIBERHED) have developed the first clinical and mechanistic classification of drugs capable of inducing fatty liver in patients who consume them. This classification, which describes the biological and molecular mechanisms that explain how these drugs cause liver damage, …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

RUVID broke the news in on Wednesday, November 26, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal